Every open market buy and sale of Editas Medicine, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $177K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when EDIT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an EDIT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every EDIT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Linda BurklyEvp, Chief Scientific Officer | Sale plan | 7,814 | $2.42 | $19K | 70,379 | Nov 13Form 4 |
| Nov 11, 2026 | Gilmore Neil O'NeillCEO | Sale plan | 21,164 | $2.42 | $51K | 265,592 | Nov 13Form 4 |
| Sep 3, 2026 | Gilmore Neil O'NeillCEO | Sale plan | 5,124 | $3.04 | $16K | 243,189 | Sep 4Form 4 |
| Sep 3, 2026 | Linda BurklyEvp, Chief Scientific Officer | Sale plan | 709 | $3.04 | $2K | 61,660 | Sep 4Form 4 |
| Sep 3, 2026 | Amy ParisonSvp, CFO | Sale plan | 453 | $3.04 | $1K | 13,839 | Sep 4Form 4 |
| Aug 3, 2026 | Amy ParisonSvp, CFO | Sale plan | 678 | $2.58 | $2K | 14,292 | Aug 5Form 4 |
| Jul 28, 2026 | Linda BurklyEvp, Chief Scientific Officer | Sale plan | 4,928 | $2.67 | $13K | 62,369 | Jul 29Form 4 |
| Jun 3, 2026 | Linda BurklyEvp, Chief Scientific Officer | Sale plan | 731 | $2.70 | $2K | 67,297 | Jun 5Form 4 |
| Jun 3, 2026 | Gilmore Neil O'NeillCEO | Sale plan | 15,380 | $2.70 | $42K | 248,313 | Jun 5Form 4 |
| Jun 3, 2026 | Amy ParisonSvp, CFO | Sale plan | 464 | $2.70 | $1K | 14,970 | Jun 5Form 4 |
| Mar 3, 2026 | Linda BurklyEvp, Chief Scientific Officer | Sale plan | 749 | $2.02 | $2K | 68,028 | Mar 4Form 4 |
| Mar 3, 2026 | Amy ParisonSvp, CFO | Sale plan | 474 | $2.02 | $957 | 15,434 | Mar 4Form 4 |
| Mar 3, 2026 | Gilmore Neil O'NeillCEO | Sale plan | 5,394 | $2.02 | $11K | 263,693 | Mar 4Form 4 |
| Dec 3, 2025 | Amy ParisonSvp, CFO | Sale plan | 461 | $2.15 | $991 | 15,908 | Dec 4Form 4 |
| Dec 3, 2025 | Gilmore Neil O'NeillCEO | Sale plan | 5,603 | $2.15 | $12K | 269,087 | Dec 4Form 4 |
EDIT insider trading FAQ
Are EDIT insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of EDIT on the open market in 0 trades, and 3 sold $177K in 16 trades, 100% of that under pre-arranged trading plans.
When did an EDIT insider last buy shares?
There has been no open market insider purchase of EDIT in the last two years.
When did an EDIT insider last sell shares?
Linda Burkly (Evp, Chief Scientific Officer) sold 7,814 shares for $19K on Nov 11, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
